Financhill
Sell
49

DE Quote, Financials, Valuation and Earnings

Last price:
$432.50
Seasonality move :
7.1%
Day range:
$425.74 - $436.50
52-week range:
$340.20 - $469.39
Dividend yield:
1.36%
P/E ratio:
16.89x
P/S ratio:
2.37x
P/B ratio:
5.14x
Volume:
2.4M
Avg. volume:
1.5M
1-year change:
11.68%
Market cap:
$117.5B
Revenue:
$50.5B
EPS (TTM):
$25.60
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $34.7B $43B $51.3B $60.2B $50.5B
Revenue Growth (YoY) -9.53% 23.94% 19.17% 17.48% -16.15%
 
Cost of Revenues $23.9B $29.3B $35.6B $37.9B $31B
Gross Profit $10.9B $13.7B $15.7B $22.3B $19.5B
Gross Profit Margin 31.27% 31.87% 30.67% 37.02% 38.59%
 
R&D Expenses $1.6B $1.6B $1.9B $2.2B $2.3B
Selling, General & Admin $3.4B $3.2B $3.6B $4.3B $4.5B
Other Inc / (Exp) $762M $932M $1.2B $881M $1.1B
Operating Expenses $6.5B $6.1B $6.7B $7.7B $8.1B
Operating Income $4.4B $7.7B $9B $14.6B $11.4B
 
Net Interest Expenses $1.2B $993M $1.1B $2.5B $3.3B
EBT. Incl. Unusual Items $3.9B $7.6B $9.1B $13B $9.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1B $1.7B $2B $2.9B $2.1B
Net Income to Company $2.8B $6B $7.1B $10.2B $7.1B
 
Minority Interest in Earnings -$2M -$2M $1M $11M $12M
Net Income to Common Excl Extra Items $2.8B $6B $7.1B $10.2B $7.1B
 
Basic EPS (Cont. Ops) $8.77 $19.14 $23.42 $34.80 $25.73
Diluted EPS (Cont. Ops) $8.69 $18.99 $23.28 $34.63 $25.62
Weighted Average Basic Share $313.5M $311.6M $304.5M $292.2M $276M
Weighted Average Diluted Share $316.6M $314M $306.3M $293.6M $277.1M
 
EBITDA $7.2B $10.6B $12.1B $17.5B $14.7B
EBIT $5.1B $8.6B $10.2B $15.5B $12.6B
 
Revenue (Reported) $34.7B $43B $51.3B $60.2B $50.5B
Operating Income (Reported) $4.4B $7.7B $9B $14.6B $11.4B
Operating Income (Adjusted) $5.1B $8.6B $10.2B $15.5B $12.6B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $9.5B $11.1B $15.3B $15.2B $10.8B
Revenue Growth (YoY) -1.39% 16.57% 37.57% -0.78% -28.57%
 
Cost of Revenues $6.7B $8B $10.4B $9.7B $6.8B
Gross Profit $2.9B $3.1B $4.8B $5.5B $4B
Gross Profit Margin 30.1% 27.86% 31.74% 36.31% 37.03%
 
R&D Expenses $443M $450M $576M $606M $626M
Selling, General & Admin $979M $752M $973M $917M $899M
Other Inc / (Exp) $149M $164M $128M $133M $246M
Operating Expenses $1.6B $1.4B $1.7B $1.8B $1.9B
Operating Income $1.2B $1.7B $3.1B $3.7B $2.1B
 
Net Interest Expenses $278M $210M $349M $782M $870M
EBT. Incl. Unusual Items $1.1B $1.6B $2.9B $3.1B $1.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $330M $330M $643M $707M $249M
Net Income to Company $758M $1.3B $2.2B $2.4B $1.2B
 
Minority Interest in Earnings -- -- $2M $1M $3M
Net Income to Common Excl Extra Items $758M $1.3B $2.2B $2.4B $1.2B
 
Basic EPS (Cont. Ops) $2.41 $4.15 $7.48 $8.30 $4.57
Diluted EPS (Cont. Ops) $2.39 $4.12 $7.44 $8.26 $4.55
Weighted Average Basic Share $314.1M $309.2M $300.6M $285.6M $272.7M
Weighted Average Diluted Share $317.2M $311.3M $302.1M $286.7M $273.8M
 
EBITDA $1.9B $2.3B $3.7B $4.3B $2.9B
EBIT $1.4B $1.8B $3.2B $3.9B $2.4B
 
Revenue (Reported) $9.5B $11.1B $15.3B $15.2B $10.8B
Operating Income (Reported) $1.2B $1.7B $3.1B $3.7B $2.1B
Operating Income (Adjusted) $1.4B $1.8B $3.2B $3.9B $2.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Revenue $34.7B $43B $51.3B $60.2B $50.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $23.9B $29.3B $35.6B $37.9B $31B
Gross Profit $10.9B $13.7B $15.7B $22.3B $19.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.6B $1.6B $1.9B $2.2B $2.3B
Selling, General & Admin $3.4B $3.2B $3.6B $4.3B $4.5B
Other Inc / (Exp) $762M $931M $1.2B $882M $1.1B
Operating Expenses $6.5B $6.1B $6.7B $7.7B $8.1B
Operating Income $4.4B $7.7B $9B $14.6B $11.4B
 
Net Interest Expenses $1.2B $993M $1.1B $2.5B $3.3B
EBT. Incl. Unusual Items $3.9B $7.6B $9.1B $13B $9.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.1B $1.7B $2B $2.9B $2.1B
Net Income to Company $2.8B $6B $7.1B $10.2B $7.1B
 
Minority Interest in Earnings -$1M -- $1M $10M $11M
Net Income to Common Excl Extra Items $2.8B $6B $7.1B $10.2B $7.1B
 
Basic EPS (Cont. Ops) $8.78 $19.13 $23.47 $34.81 $25.70
Diluted EPS (Cont. Ops) $8.70 $18.99 $23.33 $34.66 $25.60
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $7.2B $10.6B $12.1B $17.5B $14.7B
EBIT $5.1B $8.6B $10.2B $15.5B $12.6B
 
Revenue (Reported) $34.7B $43B $51.3B $60.2B $50.5B
Operating Income (Reported) $4.4B $7.7B $9B $14.6B $11.4B
Operating Income (Adjusted) $5.1B $8.6B $10.2B $15.5B $12.6B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Revenue $43B $51.3B $60.2B $50.5B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $29.3B $35.6B $37.9B $31B --
Gross Profit $13.7B $15.7B $22.3B $19.5B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.6B $1.9B $2.2B $2.3B --
Selling, General & Admin $3.2B $3.6B $4.3B $4.5B --
Other Inc / (Exp) $931M $1.2B $882M $1.1B --
Operating Expenses $6.1B $6.7B $7.7B $8.1B --
Operating Income $7.7B $9B $14.6B $11.4B --
 
Net Interest Expenses $993M $1.1B $2.5B $3.3B --
EBT. Incl. Unusual Items $7.6B $9.1B $13B $9.2B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.7B $2B $2.9B $2.1B --
Net Income to Company $6B $7.1B $10.2B $7.1B --
 
Minority Interest in Earnings -- $1M $10M $11M --
Net Income to Common Excl Extra Items $6B $7.1B $10.2B $7.1B --
 
Basic EPS (Cont. Ops) $19.13 $23.47 $34.81 $25.70 --
Diluted EPS (Cont. Ops) $18.99 $23.33 $34.66 $25.60 --
Weighted Average Basic Share $1.2B $1.2B $1.2B $1.1B --
Weighted Average Diluted Share $1.3B $1.2B $1.2B $1.1B --
 
EBITDA $10.6B $12.1B $17.5B $14.7B --
EBIT $8.6B $10.2B $15.5B $12.6B --
 
Revenue (Reported) $43B $51.3B $60.2B $50.5B --
Operating Income (Reported) $7.7B $9B $14.6B $11.4B --
Operating Income (Adjusted) $8.6B $10.2B $15.5B $12.6B --
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $7.1B $8B $4.8B $7.5B $7.3B
Short Term Investments $641M $728M $734M $946M $1.2B
Accounts Receivable, Net $4.2B $4.2B $6.4B $7.7B $5.3B
Inventory $5B $6.8B $8.5B $8.2B $7.2B
Prepaid Expenses -- $193M $185M $167M $238M
Other Current Assets -- -- -- -- --
Total Current Assets $51.4B $58.6B $64.1B $76.4B $77.7B
 
Property Plant And Equipment $13.1B $13.2B $13.1B $14.2B $15.4B
Long-Term Investments $193M $175M $117M $126M $122M
Goodwill $3.1B $3.3B $3.7B $3.9B $4B
Other Intangibles $1.3B $1.6B $1.6B $1.6B $1.5B
Other Long-Term Assets $2.4B $371M $358M $411M $559M
Total Assets $75.1B $84.1B $90B $104.1B $107.3B
 
Accounts Payable $1.9B $3.2B $3.9B $3.5B $2.7B
Accrued Expenses $3.3B $4.3B $4.9B $5.7B $5.6B
Current Portion Of Long-Term Debt $11.6B $12.9B $13.2B $15.3B $17.5B
Current Portion Of Capital Lease Obligations $318M $302M $323M $306M $303M
Other Current Liabilities -- $228M $1.2B $1.1B $2.4B
Total Current Liabilities $23.5B $27.9B $33.1B $41.1B $38.3B
 
Long-Term Debt $32.6B $32.9B $33.6B $38.5B $43.2B
Capital Leases -- -- -- -- --
Total Liabilities $62.1B $65.7B $69.7B $82.2B $84.4B
 
Common Stock $4.9B $5.1B $5.2B $5.3B $5.5B
Other Common Equity Adj -$5.5B -$2.5B -$3.1B -$3.1B -$3.7B
Common Equity $12.9B $18.4B $20.3B $21.8B $22.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $7M $3M $95M $101M $89M
Total Equity $12.9B $18.4B $20.4B $21.9B $22.9B
 
Total Liabilities and Equity $75.1B $84.1B $90B $104.1B $107.3B
Cash and Short Terms $7.7B $8.7B $5.5B $8.4B $8.5B
Total Debt $45.8B $48.4B $51.9B $63.4B $65.2B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Cash and Equivalents $7.1B $8B $4.8B $7.5B $7.3B
Short Term Investments $641M $728M $734M $946M $1.2B
Accounts Receivable, Net $4.2B $4.2B $6.4B $7.7B $5.3B
Inventory $5B $6.8B $8.5B $8.2B $7.2B
Prepaid Expenses -- $193M $185M $167M $238M
Other Current Assets -- -- -- -- --
Total Current Assets $51.4B $58.6B $64.1B $76.4B $77.7B
 
Property Plant And Equipment $13.1B $13.2B $13.1B $14.2B $15.4B
Long-Term Investments $193M $175M $117M $126M $122M
Goodwill $3.1B $3.3B $3.7B $3.9B $4B
Other Intangibles $1.3B $1.6B $1.6B $1.6B $1.5B
Other Long-Term Assets $2.4B $371M $358M $411M $559M
Total Assets $75.1B $84.1B $90B $104.1B $107.3B
 
Accounts Payable $1.9B $3.2B $3.9B $3.5B $2.7B
Accrued Expenses $3.3B $4.3B $4.9B $5.7B $5.6B
Current Portion Of Long-Term Debt $11.6B $12.9B $13.2B $15.3B $17.5B
Current Portion Of Capital Lease Obligations $318M $302M $323M $306M $303M
Other Current Liabilities -- $228M $1.2B $1.1B $2.4B
Total Current Liabilities $23.5B $27.9B $33.1B $41.1B $38.3B
 
Long-Term Debt $32.6B $32.9B $33.6B $38.5B $43.2B
Capital Leases -- -- -- -- --
Total Liabilities $62.1B $65.7B $69.7B $82.2B $84.4B
 
Common Stock $4.9B $5.1B $5.2B $5.3B $5.5B
Other Common Equity Adj -$5.5B -$2.5B -$3.1B -$3.1B -$3.7B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $7M $3M $95M $101M $89M
Total Equity $12.9B $18.4B $20.4B $21.9B $22.9B
 
Total Liabilities and Equity $75.1B $84.1B $90B $104.1B $107.3B
Cash and Short Terms $7.7B $8.7B $5.5B $8.4B $8.5B
Total Debt $45.8B $48.4B $51.9B $63.4B $65.2B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $2.8B $6B $7.1B $10.2B $7.1B
Depreciation & Amoritzation $2.1B $2.1B $1.9B $2B $2.1B
Stock-Based Compensation $81M $82M $85M $130M $208M
Change in Accounts Receivable $2B $969M -$2.5B -$4.3B $421M
Change in Inventories $397M -$2.5B -$2.1B $279M $788M
Cash From Operations $7.5B $7.7B $4.7B $8.6B $9.2B
 
Capital Expenditures $2.7B $2.6B $3.8B $4.5B $4.8B
Cash Acquisitions -$66M -$244M -$498M -$82M --
Cash From Investing -$3.3B -$5.8B -$8.5B -$8.7B -$6.5B
 
Dividends Paid (Ex Special Dividend) -$956M -$1B -$1.3B -$1.4B -$1.6B
Special Dividend Paid
Long-Term Debt Issued $9.3B $9.5B $10.4B $15.4B $18.1B
Long-Term Debt Repaid -$7.4B -$7.1B -$8.4B -$7.9B -$13.2B
Repurchase of Common Stock -$750M -$2.5B -$3.6B -$7.2B -$4B
Other Financing Activities -$133M $50M -$29M -$73M -$113M
Cash From Financing -$980M -$1.1B $826M $2.8B -$2.7B
 
Beginning Cash (CF) $4B $7.2B $8.1B $4.9B $7.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.2B $898M -$3B $2.6B $50M
Ending Cash (CF) $7.2B $8.1B $4.9B $7.6B $7.6B
 
Levered Free Cash Flow $4.8B $5.1B $911M $4.1B $4.4B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $758M $1.3B $2.2B $2.4B $1.2B
Depreciation & Amoritzation $504M $481M $452M $477M $520M
Stock-Based Compensation $18M $18M $21M $18M $49M
Change in Accounts Receivable $1.4B $1.4B -$126M $806M $2.9B
Change in Inventories $398M -$680M $435M $942M $554M
Cash From Operations $3.4B $3.4B $4.3B $5.7B $5.1B
 
Capital Expenditures $750M $878M $1.5B $1.6B $1.6B
Cash Acquisitions -- -$225M -$10M -- --
Cash From Investing -$1.8B -$2.6B -$4.1B -$4.2B -$2.8B
 
Dividends Paid (Ex Special Dividend) -$238M -$279M -$342M -$362M -$403M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $940M $2.7B $4.1B $5.5B $2.6B
Long-Term Debt Repaid -$1.6B -$1.9B -$1.9B -$2.1B -$2.4B
Repurchase of Common Stock -$487M -$758M -$1.1B -$2.6B -$780M
Other Financing Activities -$23M $130M -$22M -$30M -$25M
Cash From Financing -$2.7B -$227M $311M -$571M -$1.9B
 
Beginning Cash (CF) $8.3B $7.6B $4.5B $6.8B $7.3B
Foreign Exchange Rate Adjustment -$48M -$51M -$81M -$94M -$31M
Additions / Reductions -$1.1B $537M $537M $936M $371M
Ending Cash (CF) $7.2B $8.1B $4.9B $7.6B $7.6B
 
Levered Free Cash Flow $2.7B $2.5B $2.8B $4.1B $3.5B
Period Ending 2020-10-31 2021-10-31 2022-10-31 2023-10-31 2024-10-31
Net Income to Stockholders $2.8B $6B $7.1B $10.2B $7.1B
Depreciation & Amoritzation $2.1B $2.1B $1.9B $2B $2.1B
Stock-Based Compensation $81M $82M $85M $130M $208M
Change in Accounts Receivable $2B $969M -$2.5B -$4.3B $421M
Change in Inventories $397M -$2.5B -$2.1B $279M $788M
Cash From Operations $7.5B $7.7B $4.7B $8.6B $9.2B
 
Capital Expenditures $2.7B $2.6B $3.8B $4.5B $4.8B
Cash Acquisitions -- -$244M -$498M -- --
Cash From Investing -$3.3B -$5.8B -$8.5B -$8.7B -$6.5B
 
Dividends Paid (Ex Special Dividend) -$956M -$1B -$1.3B -$1.4B -$1.6B
Special Dividend Paid
Long-Term Debt Issued $9.3B $9.5B $10.4B $15.4B $18.1B
Long-Term Debt Repaid -$7.4B -$7.1B -$8.4B -$7.9B -$13.2B
Repurchase of Common Stock -$750M -$2.5B -$3.6B -$7.2B -$4B
Other Financing Activities -$133M $50M -$29M -$73M -$113M
Cash From Financing -$980M -$1.1B $826M $2.8B -$2.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.2B $898M -$3B $2.6B $50M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $4.8B $5.1B $911M $4.1B $4.4B
Period Ending 2021-10-31 2022-10-31 2023-10-31 2024-10-31 2025-10-31
Net Income to Stockholders $6B $7.1B $10.2B $7.1B --
Depreciation & Amoritzation $2.1B $1.9B $2B $2.1B --
Stock-Based Compensation $82M $85M $130M $208M --
Change in Accounts Receivable $969M -$2.5B -$4.3B $421M --
Change in Inventories -$2.5B -$2.1B $279M $788M --
Cash From Operations $7.7B $4.7B $8.6B $9.2B --
 
Capital Expenditures $2.6B $3.8B $4.5B $4.8B --
Cash Acquisitions -$244M -$498M -- -- --
Cash From Investing -$5.8B -$8.5B -$8.7B -$6.5B --
 
Dividends Paid (Ex Special Dividend) -$1B -$1.3B -$1.4B -$1.6B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $9.5B $10.4B $15.4B $18.1B --
Long-Term Debt Repaid -$7.1B -$8.4B -$7.9B -$13.2B --
Repurchase of Common Stock -$2.5B -$3.6B -$7.2B -$4B --
Other Financing Activities $50M -$29M -$73M -$113M --
Cash From Financing -$1.1B $826M $2.8B -$2.7B --
 
Beginning Cash (CF) $29.2B $21.2B $21.3B $25.9B --
Foreign Exchange Rate Adjustment $55M -$224M $31M -$37M --
Additions / Reductions $898M -$3B $2.6B $50M --
Ending Cash (CF) $30.1B $18B $24B $26B --
 
Levered Free Cash Flow $5.1B $911M $4.1B $4.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock